Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniele Brinch has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Physician Perceptions of JAK Inhibitor Adherence in Inflammatory Bowel Disease: A Cross-Sectional AIGO Survey

    by Elisabetta Antonelli, Cristiano Pagnini, Linda Ceccarelli, Ileana Maria Luppino, Rossella Pumpo, Andrea Cassinotti, Daniele Brinch, Massimo Bellini, Gabrio Bassotti, Maria Carla Di Paolo, et al.

    Background and Objectives: Adherence to oral therapies in inflammatory bowel disease (IBD) is a critical determinant of treatment outcomes. Janus kinase inhibitors (JAKis) are an important therapeutic advancement in IBD management, offering oral, small-molecule alternatives to biological agents. However, little is known about how clinicians perceive and assess adherence to oral small-molecule therapies. This exploratory study aimed to examine how gastroenterologists perceive, assess, and address JAKi adherence. Materials and Methods: A structured 21-item web survey was administered by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) to Italian IBD gastroenterologists in April 2025; 42 completed it. Respondents were characterized by years of experience (20 years), hospital type, and IBD patient volume (500 patients). The questionnaire addressed prescribing practices, adherence assessment methods, perceived barriers to adherence, and strategies to improve adherence. No patient-level adherence data were collected: all findings reflect physicians’ self-reported perceptions and practices. Primary analyses were restricted to the 38 respondents who had at least one patient treated with a JAKi. Proportions are reported with Wilson 95% confidence intervals; associations were explored with 279 pairwise Fisher’s exact tests, reported both uncorrected and after Benjamini–Hochberg false discovery rate (FDR) adjustment, and are hypothesis-generating. Results: Among the 38 JAKi prescribers, 86.8% (33/38; 95% CI 72.7–94.2%) considered adherence a clinical concern and all 38 (100%) reported assessing adherence in clinical practice; 37/38 (97.4%) reported doing so by direct verbal questioning and none reported using a questionnaire or validated scale. Forgetfulness (71.1%) and absence of symptoms (68.4%) were the most frequently perceived barriers; digital applications/reminders (71.1%) and dose simplification (63.2%) were the most endorsed interventions. No association was detected between adherence concern and years of IBD experience, hospital type, or patient volume in this small sample. Sixteen of 279 pairwise tests had an uncorrected p < 0.05 (14 expected by chance); none remained significant after FDR adjustment (smallest q = 0.24), and odds ratios had very wide confidence intervals. Small sample size, unknown response rate, a non-validated questionnaire, cross-sectional design, and the perception-based nature of the data limit inference and generalizability. Conclusions: Among the Italian gastroenterologists who responded to this survey and currently prescribe JAKi, adherence to oral therapy was a concern when prescribing a JAK inhibitor, and respondents reported routinely assessing adherence to therapies in clinical practice, mainly through unstructured verbal questioning. The exploratory associations among survey responses require confirmation in larger, patient-centred studies incorporating objective adherence measures.

  • Open Access

    Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study

    by Davide Scalvini, Stiliano Maimaris, Elisa Stasi, Marco Valvano, Daniele Brinch, Mario Romeo, Michele Dota, Marcello Dallio, Virginia Gregorio, Chiara Sophie Sabbione, et al.

    Background/Objectives: Adequate bowel preparation (BP) is crucial for effective colorectal cancer (CRC) surveillance in ulcerative colitis (UC). While active inflammation is known to negatively impact cleansing, data regarding predictors of BP quality specifically in UC patients with inactive disease remain limited. This study aimed to investigate risk factors for inadequate BP in UC patients in clinical/endoscopic remission and to compare the efficacy of 1L-PEG-ASC versus 2L-PEG regimens. Methods: A multicentric, retrospective, cohort study was conducted across eight Italian centers. Consecutive adult outpatients with UC undergoing colonoscopy between January-2021 and December-2022 who were in endoscopic and clinical remission were included. Boston Bowel Preparation Scale (BBPS) was assessed in patients undergoing 1L-PEG-ASC or 2L-PEG bowel preparation. Univariable and multivariable logistic regression analyses were performed to identify risk factors for inadequate BP and compare outcomes between PEG regimens. Results: A total of 379 patients were included (58% M, mean age 52.3 ± 15.4 years). The overall rate of adequate BP was 90.5%. Traditional risk factors, including demographic, clinical, and endoscopic characteristics, were not predictive of inadequate preparation in this remission cohort. Comparing regimens, 1L-PEG-ASC yielded significantly higher median total BBPS scores compared to 2L-PEG (8 [IQR 7–9] vs. 6 [IQR 6–8]; p < 0.001) and a higher exam completion rate (99.5% vs. 95.7%; p = 0.02), although the difference in adequate BP rates did not reach statistical significance (92.6% vs. 87.7%; p = 0.12). Multivariable analysis confirmed that 2L-PEG was independently associated with lower odds of achieving higher BBPS scores (OR 0.30; 95% CI 0.20–0.45). Conclusions: In UC patients with clinical and endoscopic remission, BP adequacy rates are high and comparable to the general population, suggesting that traditional IBD-related risk factors are less relevant in the absence of active inflammation. However, the 1L-PEG-ASC regimen demonstrated superior cleansing quality and exam completion rates compared to 2L-PEG. These findings support the prioritization of 1L-PEG-ASC to optimize mucosal visualization during CRC surveillance in this population.

  • A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting

    by Davide Scalvini, Cristina Bezzio, Stiliano Maimaris, Marco Vincenzo Lenti, Lusetti Francesca, Alessandro Cappellini, Carolina Cicalini, Michele Dota, Roberta Muscia, Daniele Brinch, et al.

    Background and aims: There is a paucity of data on which bowel preparation (BP) to use in an inflammatory bowel disease (IBD) outpatient setting, in particular after the introduction of 1L-PEG-ASC. Thus, we aimed to evaluate the most effective BP between 1L-PEG-ASC and 2L-PEG and to identify risk factors for inadequate BP in this IBD population. Methods: This is a multicentric, retrospective, cross-sectional study including IBD patients aged >16 years, who underwent outpatient split-dose colonoscopy between January 2021 and December 2022. Boston Bowel Preparation Scale (BBPS) was used to determine the adequacy of BP. Multivariable logistic regression was fitted to compare BP adequacy between 1L-PEG-ASC and 2L-PEG. Results: Overall, 506 patients (F 42.9%, mean age 48.9 ± 15.2 years) were included and BP was adequate in 440 (87.0%). 1L-PEG-ASC was associated with a higher rate of adequate BP compared to 2L-PEG (89.8% vs. 83.8%, P = 0.048) and higher BBPS score [median 8, interquartile range (IQR): 7–9 vs. 6, IQR: 6–8, P < 0.001]. Male sex (P = 0.03), previous ileal/colonic surgery (P = 0.01), and stricturing Crohn’s disease (CD) (P = 0.01) were associated with inadequate BP. At multivariable analysis, 1L-PEG-ASC was a predictor of adequate BP [odds ratios (OR) = 1.70, 95% confidence interval (CI): 1.00–2.90, P < 0.05]; whereas male sex (OR = 0.51, 95% CI: 0.29–0.90, P = 0.02) and previous ileal/colonic surgery (OR = 0.40, 95% CI: 0.21–0.77, P < 0.01) were confirmed as risk factors for inadequate BP. Conclusion: Results from this large real-world cohort highlight the efficiency of 1L-PEG-ASC in providing better BP compared to 2L-PEG. However, further studies are needed to validate our retrospective results and confirm the superiority of 1L-PEG-ASC. Male sex and previous ileal/colonic surgery and stricturing CD were related to poor BP.


  • Open Access

    Strategies to Enhance the Adenoma Detection Rate (ADR) and the Serrated Polyp Detection Rate (SPDR) in Colonoscopy: A Comprehensive Review

    by Davide Scalvini, Simona Agazzi, Stiliano Maimaris, Laura Rovedatti, Daniele Brinch, Alessandro Cappellini, Carlo Ciccioli, Michele Puricelli, Erica Bartolotta, Daniele Alfieri, et al.

    Introduction: High-quality colonoscopy is influenced by several factors, with the adenoma detection rate (ADR) being one of the most studied indicators. A strong inverse relationship exists between ADR and the risk of developing post-colonoscopy colorectal cancer (PCCRC), prompting the European Society of Gastrointestinal Endoscopy guidelines to recommend a minimum ADR of 25%. In contrast, there is limited evidence supporting the clinical significance of the serrated polyp detection rate (SPDR), and no specific benchmark was established until a very recent update from the American societies. Main paper: This review examines the factors that influence ADR and SPDR, offering tips to improve these metrics. Effective interventions for enhancing ADR include training, colonoscopy feedback, adequate bowel preparation, longer withdrawal time, water-aided colonoscopy, right colon second look, and chromoendoscopy. The use of cap, devices, and specialized scopes also show promise, though these are often at higher costs. Artificial intelligence has generated great optimism, especially following positive results from early randomized controlled trials; however, its effectiveness has been less pronounced in real-world settings. Conclusions: Many of these approaches require further trials and meta-analyses to establish their ultimate efficacy. Moreover, future clinical head-to-head studies will help to identify the most effective interventions for reducing colorectal cancer incidence and the risk of PCCRC.


  • Open Access

    Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital

    by Dario Genovese, Daniele Brinch, Stefano Muscarella, Marica Saladino, Lucio Carrozza, Chiara Cunsolo, Giuseppa Luisa Sanfilippo, Emanuele Amodio, Maria Cappello, Donatella Ferraro

    Introduction: Inflammatory bowel diseases (IBDs) require immunosuppressive drugs like biologics. All IBD patients, including those on biological therapy, should be vaccinated against COVID-19, according to the ECCO recommendations. IBD patients on anti-TNF treatment exhibited lower COVID-19 vaccine responses; however, SARS-CoV-2 variant neutralizing antibody titers have been seldom studied. Methods: IBD patients and healthcare professionals (control group) were tested for COVID-19 vaccine immunogenicity by neutralizing antibody titers against Wild-Type SARS-CoV-2 and its variants. IBD patients were assigned to no treatment/mesalamine, anti-TNF biologic therapy, or non-anti-TNF biologic therapy. The study was performed in a tertiary hospital in Palermo, Sicily, from May to July 2021. Results: In total, 107 IBD patients and 41 healthcare workers were enrolled. A total of 46 patients received mesalamine or no medication, 28 received anti-TNF biologics, and 33 received non-anti-TNF biologics. No significant differences were found in age, gender, or timing of blood sampling post vaccination. Omicron neutralizing activity was markedly reduced in all groups (p < 0.001). The group of patients on anti-TNF biologics showed lower neutralizing antibody titers against Alpha, Delta, and Gamma strains than every other group analyzed. Conclusions: IBD patients on anti-TNF drugs have a reduced serological response to the SARS-CoV-2 vaccine, with the Omicron variant not being neutralized. This highlights the necessity for tailored vaccine strategies for these patients.

  • Open Access

    Prevalence, Risk Factors and Association with Clinical Outcomes of Malnutrition and Sarcopenia in Inflammatory Bowel Disease: A Prospective Study

    by Cristina Bezzio, Daniele Brinch, Davide Giuseppe Ribaldone, Maria Cappello, Natalie Ruzzon, Marta Vernero, Davide Scalvini, Laura Loy, Sofia Donghi, Stefania Ciminnisi, et al.

    Introduction: The prevalences of malnutrition and sarcopenia in patients with IBD are not precisely known, and nutritional assessment is not standardized. We assessed the prevalence and risk factors of these conditions in outpatients and their impact on clinical outcomes. Methods: This prospective longitudinal study considered patients who had IBD for at least one year, were attending a tertiary IBD center, and were followed for the subsequent year. Results: In a sample of 158 consecutive patients (96 with Crohn’s disease and 62 with ulcerative colitis), the prevalence of malnutrition, according to GLIM criteria, was 13.3%. For identifying patients at risk of malnutrition, the Malnutrition Universal Screening Tool demonstrated better accuracy, (sensitivity 88.9 (65.3–98.6) and specificity 90.2 (83.8–93.4)) than the SaskIBD-NR questionnaire (sensitivity 69.3 (41.1–86.7) and specificity 60.9 (60.9–76.8)). The prevalence of sarcopenia was 34.2%. Considering clinical outcomes, sarcopenia at baseline was significantly associated with hospital admission within a year (p = 45.2% vs. 20.3%, 0.026). Conclusions: Malnutrition and sarcopenia were present in about one-third of IBD patients. Awareness should be raised among physicians caring for IBD patients about the need to evaluate patients’ nutritional statuses to help patients achieve a better quality of life.


  • Open Access

    A Case of Foreign Body in the Biliary Tree and the Challenge of Hypereosinophilia

    by Emanuele Sinagra, Francesco Vito Mandarino, Francesca Rossi, Rita Alloro, Sergio Testai, Marta Marasà, Serena Cristofalo, Marcello Maida, Daniele Brinch, Giuseppe Conoscenti, et al.

    In all reported cases of foreign body migration or impaction in the biliary tree, there is no mention of the presence of hypereosinophilia among the laboratory findings. This could possibly be attributed to the local tissue reaction caused by the impacted foreign body. Here, we present our experience with the removal of a screw from a surgical retractor that became lodged in the common bile duct (CBD) and migrated in a patient who had previously undergone a left lateral hepatectomy for hepatic hydatidosis. The imaging was not sufficient to make a diagnosis, and the interpretation of hypereosinophilia in such a case could pose a challenge.


  • Open Access

    Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic

    by Vincenzo Di Stefano, Antonino Lupica, Paolo Alonge, Antonia Pignolo, Sofia Maria Augello, Francesca Gentile, Andrea Gagliardo, Francesca Giglia, Daniele Brinch, Maria Cappello, et al.

    Background and purpose: Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‐PN) is caused by mutations in the TTR gene, leading to misfolded monomers that aggregate generating amyloid fibrils.Methods: A prospective systematic genetic screening for ATTRv‐PN was proposed in patients presenting with a sensory–motor idiopathic polyneuropathy and two or more “red flags” among the following: family history of polyneuropathy or cardiopathy, bilateral carpal tunnel syndrome, cardiac insufficiency, renal amyloidosis, lumbar tract stenosis, autonomic dysfunction, idiopathic gastrointestinal disease, amyloid deposits on biopsy, and vitreous opacities. The detection rate was calculated, and nonparametric analyses were carried out to underline differences among screened positive versus negative patients.Results: In the first step, 145 suspected patients underwent genetic testing, revealing a diagnosis of ATTRv‐PN in 14 patients (10%). Then, cascade screening allowed early recognition of 33 additional individuals (seven symptomatic ATTRv‐PN patients and 26 presymptomatic carriers) among 84 first‐degree relatives. Patients with a positive genetic test presented a higher frequency of unexplained weight loss, gastrointestinal symptoms, and family history of cardiopathy.Conclusions: A systematic screening for ATTRv‐PN yielded an increased recognition of the disease in our neurological clinic. Unexplained weight loss associated with axonal polyneuropathy had the highest predictive value in the guidance of clinical suspicion. A focused approach for the screening of ATTRv‐PN could lead to an earlier diagnosis and identification of asymptomatic carriers, who will be promptly treated after a strict follow‐up at the clinical onset.


  • Open Access

    Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease

    by Francesco Vito Mandarino, Emanuele Sinagra, Alberto Barchi, Maria Chiara Verga, Daniele Brinch, Dario Raimondo, Silvio Danese

    Gastroparesis (GP) is a disorder of gastric functions that is defined by objective delayed gastric emptying in the absence of mechanical obstruction. This disease is characterized by symptoms such as nausea, post-prandial fullness, and early satiety. GP significantly impacts patients’ quality of life and contributes to substantial healthcare expenses for families and society. However, the epidemiological burden of GP is difficult to evaluate, mainly due its significant overlap with functional dyspepsia (FD). GP and FD represent two similar diseases. The pathophysiology of both disorders involves abnormal gastric motility, visceral hypersensitivity, and mucosal inflammation. Moreover, both conditions share similar symptoms, such as epigastric pain, bloating, and early satiety. The latest evidence reveals that dysbiosis is directly or indirectly connected to gut–brain axis alterations, which are the basis of pathogenesis in both FD and GP. Furthermore, the role of microbiota in the development of gastroparesis was demonstrated by some clinical studies, which found that the use of probiotics is correlated with improvements in the gastric emptying time (GET). Infections (with viruses, bacteria, and protozoa) represent a proven etiology for GP but have not been sufficiently considered in current clinical practice. Previous viral infections can be found in about 20% of idiopathic GP cases. Moreover, delayed gastric emptying during systemic protozoal infections represents a huge concern for compromised patients, and few data exist on the topic. This comprehensive narrative review analyzes the relationship between microorganisms and GP. We explore, on the one hand, the correlation between gut microbiota dysbiosis and GP pathogenesis, including treatment implications, and, on the other hand, the association between exogenous infections and the etiology of the disease.


  • Open Access

    Telemedicine Is an Effective Tool to Monitor Disease Activity in IBD Patients in the COVID-19 Era: A Single Centre Experience Based on Objective Data

    by Emanuele Sinagra, Anita Busacca, Laura Guida, Lucio Carrozza, Daniele Brinch, Federica Crispino, Marcello Maida, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, et al.

    Background: The COVID-19 outbreak has led IBD clinics to adopt a remote monitoring approach in order to guarantee an adequate follow-up of patients with inflammatory bowel disease (IBD) and ensure the rules of social distancing. Aim: The aim of the study was to perform a survey on IBD patients who underwent remote monitoring in our tertiary referral center, to assess adherence, patients’ perceptions and satisfaction, and finally their opinions for future monitoring. Furthermore, we evaluated changes in disease activity and Quality of Life (QoL) using validated questionnaires. Methods: Consecutive patients with IBD scheduled for follow-up visits were switched to remote monitoring through e-mail from March 2020 to February 2021. Patients were asked to complete a questionnaire focusing on the following elements of the intervention: (1) self-assessment questions, (2) action plans, and (3) educational messages. Results: Four hundred and twenty four Caucasian patients completed the survey. 233 (55.1%) were male, 220 (52.0%) had Crohn’s Disease (CD). Median baseline Mayo Score and Harvey Bradshaw Index were 3 and 4, respectively. 9 (2.1%) patients were referred to the emergency department because of disease flares. 410 (96.9%) patients were satisfied with telemedicine, and 320 (76.5%) patients reported that they would maintain this approach also after COVID-19 pandemic. Overall, on univariate logistic regression analysis, none of the variables were related to patients’ satisfaction or to an improved QoL. The presence of ulcerative colitis was associated with the need for treatment change. Conclusions: Our results suggest that a telemedicine approach is well accepted by patients with IBD and could represent an effective tool in monitoring disease activity. Further controlled studies are warranted to properly assess if telemedicine can replace face-to-face consultations in IBD.